Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis.
about
Evaluation of an mHealth Medication Regimen Self-Management Program for African American and Hispanic Uncontrolled HypertensivesInterventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.Factors Associated with Medication Nonadherence among Hypertensives in Ghana and NigeriaPersistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.Characteristics Associated With Antihypertensive Treatment and Blood Pressure Control: A Population-Based Follow-Up Study in Peru.Weight loss intervention adherence and factors promoting adherence: a meta-analysis.Social support and adherence to treatment in hypertensive patients: a meta-analysis.Choosing wisely in case of hypertension, diabetes and hyperlipidemia in older patients.Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects.Patient non-adherence: an interpretative phenomenological analysis.Factors associated with antihypertensive medication non-adherence: a systematic review.Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study.Not all texts are created equal: Design considerations for text message interventions to improve antihypertensive medication adherence.The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study.Primary nonadherence to chronic disease medications: a meta-analysis.
P2860
Q33446007-65FD5863-F660-4137-9B73-2E6FB1E4ADA8Q36042709-501DFC4F-C7A4-4881-990C-B5CF27B7CCF0Q36174892-EBB7E0AB-7030-4D5F-BB24-B17A678E8BD6Q36400538-A8E8381F-7153-463D-B3A7-796CF3358355Q36832571-88514012-8C69-4089-8DC9-B4D4BBDF159AQ37187710-D84071E4-6BC4-41C2-BCF4-1DDA91F0CDE1Q38262351-21FA6D39-AFDC-4452-83F4-DCE74761A5B8Q38711884-9078E561-3D2A-4BD2-8D35-5B3F0EE6C5C8Q38865956-A5460830-7C4B-4A3D-82DD-0585B0E36CC5Q38871376-E133104B-DC9E-4625-8C52-0525CF4A23DEQ39404359-395E7B78-E971-4CAB-BDAC-5E83209FB071Q40677101-2C02AE07-76BC-498A-BA80-727CBE84A6A2Q48299756-48111FDA-C436-4906-BA38-05025F0E9591Q51765491-241A1AAC-8CC6-4C0F-9638-02B1AB2F8086Q55262809-23E50217-28CD-4B64-853C-ECB4F8F4AE68
P2860
Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proportion and risk indicators ...... sive therapy: a meta-analysis.
@en
Proportion and risk indicators ...... sive therapy: a meta-analysis.
@nl
type
label
Proportion and risk indicators ...... sive therapy: a meta-analysis.
@en
Proportion and risk indicators ...... sive therapy: a meta-analysis.
@nl
prefLabel
Proportion and risk indicators ...... sive therapy: a meta-analysis.
@en
Proportion and risk indicators ...... sive therapy: a meta-analysis.
@nl
P2860
P356
P1476
Proportion and risk indicators ...... sive therapy: a meta-analysis.
@en
P2093
M Wasem Alsabbagh
Mark Lemstra
P2860
P304
P356
10.2147/PPA.S55382
P407
P577
2014-02-13T00:00:00Z